Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 655

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Summing up evidence: one answer is not always enough

Lau, Joseph, Ioannidis, John PA, Schmid, Christopher H·1998·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(97)08468-7

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 38

  1. Chalmers, 1993, Meta-analysis stimulus for changes in clinical trials, Stat Meth Med Res, 2, 161, 10.1177/096228029300200204 · DOI
  2. Antman, 1992, A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction, JAMA, 268, 240, 10.1001/jama.1992.03490020088036 · DOI · Paper page
  3. Teo, 1991, Effect of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials, BMJ, 303, 1499, 10.1136/bmj.303.6816.1499 · DOI
  4. Sacks, 1990, Endoscopic hemostasis: an effective therapy for bleeding peptic ulcers, JAMA, 264, 494, 10.1001/jama.1990.03450040090037 · DOI
  5. Ioannidis, 1996, Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates: an example from patient populations in trials of human immunodeficiency virus infection, Am J Epidemiol, 144, 1074, 10.1093/oxfordjournals.aje.a008881 · DOI
  6. Topol, 1992, Answers to complex questions cannot be derived from “simple” trials, Br Heart J, 68, 348, 10.1136/hrt.68.10.348 · DOI
  7. Anello, 1995, Exploratory or analytic meta-analysis: should we distinguish between them?, J Clin Epidemiol, 48, 109, 10.1016/0895-4356(94)00084-4 · DOI
  8. Naylor, 1996, The case for failed meta-analyses, J Eval Clin Pract, 1, 127, 10.1111/j.1365-2753.1995.tb00018.x · DOI
  9. Ioannidis, 1996, On meta-analyses of meta-analyses, Lancet, 348, 756, 10.1016/S0140-6736(05)65647-4 · DOI
  10. Woods, 1992, Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2), Lancet, 339, 1553, 10.1016/0140-6736(92)91828-V · DOI · Paper page
  11. 1995, ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X · DOI
  12. 1994, effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction, Lancet, 343, 1115
  13. 1994, CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women, Lancet, 343, 619, 10.1016/S0140-6736(94)92633-6 · DOI · Paper page
  14. Bucher, 1996, Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials, JAMA, 275, 1113, 10.1001/jama.1996.03530380055031 · DOI
  15. Villar, 1995, Predictive ability of meta-analyses of randomised controlled trials, Lancet, 345, 772, 10.1016/S0140-6736(95)90646-0 · DOI
  16. Lelorier, 1997, Discrepancies between meta-analyses and subsequent large randomized, controlled trials, N Engl J Med, 337, 536, 10.1056/NEJM199708213370806 · DOI
  17. JP Ioannidis JC Cappelleri J Lau Large trials and meta-analyses. N Engl J Med (in press).
  18. Berlin, 1994, Advantages and limitations of meta-analytic regressions of clinical trials data, Online J Curr Clin Trials, 134
  19. Smith, 1993, Cholesterol lowering and mortality: the importance of considering initial level of risk, BMJ, 306, 1367, 10.1136/bmj.306.6889.1367 · DOI
  20. Boissel, 1993, An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients, J Cardiovasc Pharmacol, 22, 356, 10.1097/00005344-199309000-00003 · DOI
  21. Ioannidis, 1997, Clinical efficacy of antiretroviral changes in treatment-experienced HIV infected patients: a meta-analysis, Online J Curr Clin Trials, 204
  22. Cappelleri, 1995, Efficacy and safety of different aspirin dosages on vascular diseases; a meta-regression analysis, Online J Curr Clin Trials, 174
  23. Ioannidis, 1996, A metaanalysis of the relative efficacy and toxicity of P carinii prophylactic regimens, Arch Intern Med, 156, 177, 10.1001/archinte.1996.00440020081010 · DOI
  24. Morgenstem, 1982, Uses of ecologic analysis in epidemiologic research, Am J Public Health, 72, 1336, 10.2105/AJPH.72.12.1336 · DOI · Paper page
  25. Yusuf, 1984, Why do we need some large, simple, randomized trials?, Stat Med, 3, 409, 10.1002/sim.4780030421 · DOI · Paper page
  26. Stewart, 1995, Practical methodology of meta-analyses (overviews) using updated individual patient data: Cochrane Working Group, Stat Med, 14, 2057, 10.1002/sim.4780141902 · DOI · Paper page
  27. 1995, Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials, N Engl J Med, 333, 1444, 10.1056/NEJM199511303332202 · DOI · Paper page
  28. McIntosh, 1996, The population risk as an explanatory variable in research synthesis of clinical trials, Stat Med, 15, 1713, 10.1002/(SICI)1097-0258(19960830)15:16<1713::AID-SIM331>3.0.CO;2-D · DOI
  29. Senn, 1994, Importance of trends in the interpretation of an overall odds ratio the meta-analysis of clinical trials, Stat Med, 13, 293, 10.1002/sim.4780130310 · DOI
  30. Sharp, 1996, The relation between treatment benefit and underlying risk in meta-analysis, BMJ, 313, 735, 10.1136/bmj.313.7059.735 · DOI
  31. CH Schmid J Lau M McIntosh JC Cappelleri An empirical study of the effect of the control rate as a predictor of treatment efficacy in metaanalysis of clinical trials. Stat Med (in press).
  32. Ioannidis, 1997, The impact of high risk patients on the results of clinical trials, J Clin Epidemiol, 50, 1089, 10.1016/S0895-4356(97)00149-2 · DOI
  33. Woods, 1995, Mega-trials and management of acute myocardial infarction, Lancet, 346, 611, 10.1016/S0140-6736(95)91440-4 · DOI
  34. Rubin, 1992, Meta-analysis: literature synthesis or effect-size surface estimation?, J Educ Stat, 17, 363, 10.2307/1165129 · DOI
  35. Glasziou, 1995, An evidence based approach to individualising treatment, BMJ, 311, 1356, 10.1136/bmj.311.7016.1356 · DOI
  36. Moher, 1995, Meta-analysis of randomized controlled trials: a concern for standards, JAMA, 274, 1962, 10.1001/jama.1995.03530240072044 · DOI
  37. Chalmers, 1996, Changes in clinical trials mandated by the advent of meta-analysis, Stat Med, 15, 1263, 10.1002/(SICI)1097-0258(19960630)15:12<1263::AID-SIM305>3.0.CO;2-K · DOI
  38. Lau, 1995, Cumulative meta-analysis builds evidence for exemplary medical care, J Clin Epidemiol, 48, 45, 10.1016/0895-4356(94)00106-Z · DOI

Cited by

Metadata

Authors
Lau, J., Ioannidis, J. P., & Schmid, C. H.
Venue
The Lancet
Publisher
Elsevier BV
Published
1998-01
Volume
351
Issue
9096
Pages
123-127
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2018152980
Cited by
655
References
9
FWCI
50.56
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.